SAN ANTONIO - Construction is underway at the so-called “Can Opener” intersection at Loop 1604 and Schuwirth Road on the East Side, known for its frequent crashes. With more than 100 crashes recorded ...

"Antifa" is in Donald Trump's sights. Following the assassination of conservative activist Charlie Kirk, Trump has blamed "radical leftists" for pushing political violence against those on the ...

Parents at a Brisbane kindergarten are being urged to not pay for their own child’s artwork after this masthead revealed families at a C&K affiliated centre were told to cough up $2200 to cover debts.

Engineered with advanced PrecisionCore® technology, ColorWorks color label printers provide full-color capabilities, flexible customization and single-step labeling simplicity while consistently ...

LOS ALAMITOS, Calif., Sept. 16, 2025 /PRNewswire/ -- Epson today announced it will be showcasing its ColorWorks ® on-demand color labeling solutions at PACK EXPO Las Vegas from Sept. 29 to Oct. 1 at ...

President Donald Trump says he wants to change the name of the Department of Defense back to its original title: the Department of War. Speaking to reporters in the Oval Office on Monday, the ...

Will Donald Trump's threat to use secondary sanctions slow Russian aggression or dampen its economy? Some see them as a powerful deterrent, while others think they ...

Our editors work with affiliates when we select some or all of the products featured. We will receive compensation from retailers and/or from purchases through these links. Last month, Miu Miu's new ...

The Government of India has made it mandatory for the top 300 pharmaceutical companies to print or affix QR (Quick Response) codes on the packaging of the medicines they sell. These codes, which can ...

- Primary Endpoint Analysis Confirms Favorable Tolerability Profile of ATI-2138 Without Certain Risks Associated with Other Agents in the Class - - Efficacy Results Show Comparable Outcomes to ...

WAYNE, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for ...